Company intelligence / Profile preview

ICL Group

Ownership: Public · ICL
Employees: ~12000
Development stage: Commercial

Overview

ICL Group is a leading global specialty minerals and chemicals company, focused on sustainable solutions in agriculture, food technology, and industrial products. It supplies high-purity minerals to the pharmaceutical and nutraceutical industries but does not develop therapeutics or clinical-stage drugs.

Industry: Chemicals & Materials

Partnerships

Evogene/Lavie Bio (AI-driven biostimulant discovery for agriculture)

Beyond the preview

Go deeper on ICL Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ICL Group.

Explore the full profile